The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of TAS-OX (TAS-102 and oxaliplatin) plus bevacizumab for late-line colorectal cancer.
 
Howard S. Hochster
Stock and Other Ownership Interests - Compass Therapeutics; Processa Pharmaceuticals
Consulting or Advisory Role - Bayer; Genentech; Merck
Speakers' Bureau - Natera
 
Hao Liu
No Relationships to Disclose
 
Lyudmyla Derby Berim
No Relationships to Disclose
 
Kristen Renee Spencer
Consulting or Advisory Role - Caris Life Sciences; Helsinn Therapeutics; Lynx Group; QED Therapeutics
 
Pat Gulhati
No Relationships to Disclose
 
Manda DiRubbo
No Relationships to Disclose
 
Seth D. Cohen
No Relationships to Disclose
 
Patrick Lee
No Relationships to Disclose
 
Stuart P. Leitner
No Relationships to Disclose
 
Delia Radovich
No Relationships to Disclose
 
Christian Misdary
Employment - Becton Dickinson
 
Christian Perez
No Relationships to Disclose
 
Sutirtha Datta
No Relationships to Disclose
 
Andrea Gonzalez
Stock and Other Ownership Interests - Abbott
 
Tracie Saunders
No Relationships to Disclose
 
Patrick M Boland
Consulting or Advisory Role - Bayer; Guardant Health; Merck; Pfizer
Research Funding - Amgen (Inst); Macrogenics (Inst); Merck (Inst); Processa Pharmaceuticals (Inst)